Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

The effects of nicotine and cigarette smoke on the monoamine transporters.

Danielson K, Truman P, Kivell BM.

Synapse. 2011 Sep;65(9):866-79. doi: 10.1002/syn.20914. Epub 2011 Mar 10. Review.

PMID:
21308797
2.

Nicotine replacement to aid smoking cessation.

[No authors listed]

Drug Ther Bull. 1999 Jul;37(7):52-4. Review.

PMID:
10692714
3.

The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation.

Escobar-Chávez JJ, Merino V, López-Cervantes M, Rodríguez-Cruz IM, Quintanar-Guerrero D, Ganem-Quintanar A.

Curr Drug Discov Technol. 2009 Sep;6(3):171-85. Epub 2009 Sep 1. Review.

PMID:
19496753
4.

Serotonin receptors as potential targets for modulation of nicotine use and dependence.

Fletcher PJ, Lê AD, Higgins GA.

Prog Brain Res. 2008;172:361-83. doi: 10.1016/S0079-6123(08)00918-7. Review.

PMID:
18772042
5.

Biological aspects of the link between smoking and depression.

Quattrocki E, Baird A, Yurgelun-Todd D.

Harv Rev Psychiatry. 2000 Sep;8(3):99-110. Review.

PMID:
10973935
6.
7.

Nicotine and non-nicotine smoking cessation pharmacotherapies.

Frishman WH, Mitta W, Kupersmith A, Ky T.

Cardiol Rev. 2006 Mar-Apr;14(2):57-73. Review.

PMID:
16493243
8.

Efficacy and safety of varenicline for smoking cessation.

Hays JT, Ebbert JO, Sood A.

Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Review.

PMID:
18342165
9.

Emerging pharmacotherapies for smoking cessation.

Garwood CL, Potts LA.

Am J Health Syst Pharm. 2007 Aug 15;64(16):1693-8. Review. Erratum in: Am J Health Syst Pharm. 2007 Oct 1;64(19):1995.

PMID:
17687057
10.

Disruption of nicotine conditioning by dopamine D(3) receptor ligands.

Le Foll B, Schwartz JC, Sokoloff P.

Mol Psychiatry. 2003 Feb;8(2):225-30.

PMID:
12610655
11.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
13.

Nicotinic receptor-based therapeutics and candidates for smoking cessation.

Dwoskin LP, Smith AM, Wooters TE, Zhang Z, Crooks PA, Bardo MT.

Biochem Pharmacol. 2009 Oct 1;78(7):732-43. doi: 10.1016/j.bcp.2009.06.002. Epub 2009 Jun 10. Review.

14.

Smoking cessation pharmacotherapy.

Frishman WH.

Ther Adv Cardiovasc Dis. 2009 Aug;3(4):287-308. doi: 10.1177/1753944709335754. Epub 2009 Jun 2. Review.

PMID:
19491139
15.

Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.

Balfour DJ, Fagerström KO.

Pharmacol Ther. 1996;72(1):51-81. Review.

PMID:
8981571
16.

Nicotine vaccines for smoking cessation.

Murtagh J, Foerster V.

Issues Emerg Health Technol. 2007 Sep;(103):1-4.

PMID:
17896445
17.

Neurobiology of nicotine addiction: implications for smoking cessation treatment.

Benowitz NL.

Am J Med. 2008 Apr;121(4 Suppl 1):S3-10. doi: 10.1016/j.amjmed.2008.01.015. Review.

PMID:
18342164
18.

Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine.

Benowitz NL, Zevin S, Jacob P 3rd.

J Pharmacol Exp Ther. 1998 Dec;287(3):958-62.

19.

Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.

Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M.

Tob Control. 2010 Apr;19(2):98-103. doi: 10.1136/tc.2009.031567.

PMID:
20378585
20.

The effects of nicotine and tobacco particulate matter on dopamine uptake in the rat brain.

Danielson K, Putt F, Truman P, Kivell BM.

Synapse. 2014 Feb;68(2):45-60. doi: 10.1002/syn.21715. Epub 2013 Sep 30.

PMID:
23999947

Supplemental Content

Support Center